USD
$0.00
(0.00%
)At Close (As of Oct 24, 2025)
$2.59B
Market Cap
30.41
P/E Ratio
2.43
EPS
$146.36
52 Week High
$66.50
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | $459M |
| Total Revenue | $1.7B |
| Cost Of Revenue | $1.3B |
| Costof Goods And Services Sold | $1.3B |
| Operating Income | $208M |
| Selling General And Administrative | $185M |
| Research And Development | $53M |
| Operating Expenses | $251M |
| Investment Income Net | - |
| Net Interest Income | -$56M |
| Interest Income | - |
| Interest Expense | $56M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $107M |
| Income Before Tax | $148M |
| Income Tax Expense | $27M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $121M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $204M |
| Ebitda | $311M |
| Net Income | $120M |
| Field | Value (USD) |
|---|---|
| Total Assets | $3.1B |
| Total Current Assets | $671M |
| Cash And Cash Equivalents At Carrying Value | $47M |
| Cash And Short Term Investments | $47M |
| Inventory | $247M |
| Current Net Receivables | $349M |
| Total Non Current Assets | $2.4B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $778M |
| Intangible Assets Excluding Goodwill | $778M |
| Goodwill | $1B |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | - |
| Other Current Assets | $28M |
| Other Non Current Assets | - |
| Total Liabilities | $1.5B |
| Total Current Liabilities | $227M |
| Current Accounts Payable | $101M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $22M |
| Total Non Current Liabilities | $1.2B |
| Capital Lease Obligations | $113M |
| Long Term Debt | $980M |
| Current Long Term Debt | $10M |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $1.1B |
| Other Current Liabilities | $113M |
| Other Non Current Liabilities | $25M |
| Total Shareholder Equity | $1.6B |
| Treasury Stock | - |
| Retained Earnings | $891M |
| Common Stock | $34K |
| Common Stock Shares Outstanding | $36M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $205M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $111M |
| Capital Expenditures | $106M |
| Change In Receivables | - |
| Change In Inventory | -$18M |
| Profit Loss | - |
| Cashflow From Investment | -$195M |
| Cashflow From Financing | $13M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $120M |
| Field | Value (USD) |
|---|---|
| Gross Profit | $459M |
| Total Revenue | $1.7B |
| Cost Of Revenue | $1.3B |
| Costof Goods And Services Sold | $1.3B |
| Operating Income | $208M |
| Selling General And Administrative | $185M |
| Research And Development | $53M |
| Operating Expenses | $251M |
| Investment Income Net | - |
| Net Interest Income | -$56M |
| Interest Income | - |
| Interest Expense | $56M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $107M |
| Income Before Tax | $148M |
| Income Tax Expense | $27M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $121M |
| Comprehensive Income Net Of Tax | - |
| Ebit | $204M |
| Ebitda | $311M |
| Net Income | $120M |
Sector: HEALTHCARE
Industry: MEDICAL DEVICES
Integer Holdings Corporation is a prominent outsourced manufacturer of advanced medical devices, focusing on innovative solutions within the cardiovascular, neuromodulation, advanced surgical, and portable medical sectors. Headquartered in Plano, Texas, the company leverages a robust global manufacturing network spanning the United States, Puerto Rico, and Costa Rica to ensure high-quality production and supply chain optimization. Integer's dedication to innovation and operational excellence solidifies its reputation as a reliable partner for OEMs and healthcare providers, striving to enhance patient outcomes on a worldwide scale.